Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated from v3.5.3 to v3.5.4, indicating a new page version. This is a metadata/version update and does not modify the study content or data presented.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays the updated site revision, v3.5.3, replacing the previous v3.5.2; this indicates a software deployment rather than a change to trial information.
    Difference
    0.1%
    Check dated 2026-04-30T16:47:30.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.5.0 to v3.5.2. This appears to be a minor maintenance update and does not modify study data or visible content.
    Difference
    0.1%
    Check dated 2026-04-16T10:34:04.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T16:49:12.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-03-11T15:21:27.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed notices for Revision: v3.4.1 and a government funding status notice. These are administrative site updates and do not affect the study details on the page.
    Difference
    0.5%
    Check dated 2026-02-11T09:17:23.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.